LadRx Corporation Issues Corporate Update for 3Q22

LOS ANGELES--(BUSINESS WIRE)--LadRx Corporation (OTCQB: LADX) (“LadRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today issued the below update to stockholders. *** Dear Stockholders, Welcome to LadRx’s latest update for the quarter ending September 30, 2022. Please see our 10Q filed on...

Click to view original post